In 2020, Oregon was the first state in the U.S. to effectively legalize psilocybin, the hallucinogenic component of magic mushrooms, for therapeutic use.
It has shown to be effective in treating post-traumatic stress disorder, depression and end-of-life anxiety.
Since then, regulations and restrictions for psilocybin treatment have taken shape across the state with many rural counties opting out of providing any psilocybin-related services at all.
Read more
A new study on microdosing LSD did not find any beneficial long-term changes in mood or cognition.
Read more
This article from The Guardian states: The ketamine industry, like the wide psychedelic industry, is experiencing growing pains.
One of the largest startup clinic chains offering ketamine treatment has just gone bust, another is in dire straits, and others face uncertainty.
Why are so many ketamine clinics struggling, even as demand is increasing?
Read more